Literature DB >> 22728751

Monotherapy with atazanavir as a simplification strategy: results from an observational study.

Francesca Cossarini, Stefania Salpietro, Laura Galli, Nicola Gianotti, Silvia Nozza, Vincenzo Spagnuolo, Hamid Hasson, Simona Bossolasco, Adriano Lazzarin, Giuseppe Tambussi, Antonella Castagna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22728751     DOI： 10.1097/QAI.0b013e318258bf3c

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  2 in total

1.  Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service.

Authors:  Umberto Restelli; Massimo Andreoni; Andrea Antinori; Marzia Bonfanti; Giovanni Di Perri; Massimo Galli; Adriano Lazzarin; Giuliano Rizzardini; Davide Croce
Journal:  Clinicoecon Outcomes Res       Date:  2014-09-23

2.  Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial.

Authors:  Umberto Restelli; Massimiliano Fabbiani; Simona Di Giambenedetto; Carmela Nappi; Davide Croce
Journal:  Clinicoecon Outcomes Res       Date:  2017-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.